ImmunityBio, Inc. IBRX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Other revenues | $337K-40.1% | $306K-48.6% | $639K+64.7% | $510K+60.4% | $563K+86.4% | |
| Product revenue, net | $140.64M+359% | $112.98M+698% | $81.92M+1,080% | $56.09M+5,566% | $30.66M— | |
| Revenue by Geography | ||||||
| Europe | $302K-40.3% | $278K-47.6% | $597K+73.7% | $455K+22.5% | $506K+8.1% | |
| U.S. | $140.68M+358% | $113.01M+695% | $81.96M+1,070% | $56.15M+5,370% | $30.72M+80,203% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ImmunityBio, Inc. break its business down?
- ImmunityBio, Inc. (IBRX) reports total revenue by product across 2 parts — Other revenues and Product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does ImmunityBio, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ImmunityBio, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
